Track which hedge funds hold Halozyme Therapeutics Inc and how their positions changed over time.
Current Holders
222
Showing
5
| $885.3M |
| 0.0% |
33 |
| VANGUARD GROUP INC | 2025-Q4 | Decreased | 11.6M | -0.5% | $778.5M | 0.0% | 0 |
| STATE STREET CORP | 2025-Q4 | Increased | 5.1M | +2.0% | $344.7M | 0.0% | 32 |
| Invesco Ltd. | 2025-Q4 | Increased | 3.6M | +12.4% | $245.5M | 0.0% | 35 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2025-Q4 | Decreased | 3.2M | -2.1% | $216.9M | 0.1% | 0 |
Showing 5 of 222 results.PROUpgrade to see all → |
Upgrade to Pro for 2 years of historical data, full analytics access, and CSV exports
Starting at $16/mo billed annually